Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-21

Clinical Trial Update: Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers. [NA]

View source ↗

Summary

Completed clinical trial evaluating Artacent Amniotic Tissue for treatment of chronic lower-extremity ulcers in people with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artacent Amniotic Tissue

Snippet

Sponsor: Tides Medical | Conditions: Lower Extremity Chronic Ulcers in Diabetics, Diabetic Foot Ulcer (DFU) | NA | Status: COMPLETED